|
Prednisolone Tebutate Injectable Suspension
» Prednisolone Tebutate Injectable Suspension is a sterile suspension of Prednisolone Tebutate in a suitable aqueous medium. It contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of C27H38O6.
Packaging and storage
Preserve in single-dose or in multiple-dose containers, preferably of Type I glass.
Identification, Ultraviolet Absorption
Solution:
Bacterial endotoxins
pH
Other requirements
It meets the requirements under Injections
Assay
Mobile solvent
Prepare a mixture of isooctane, tetrahydrofuran, and alcohol (89:10:8).
Standard preparation
Dissolve an accurately weighed quantity of USP Prednisolone Tebutate RS in a mixture of tetrahydrofuran and isooctane (1:1) to obtain a solution having a known concentration of about 1 mg per mL.
Assay preparation
Transfer to a separator an accurately measured volume, freshly mixed, of Injectable Suspension, equivalent to about 100 mg of prednisolone tebutate, and dilute with about 10 mL of water. Extract with three 25-mL portions of methylene chloride, filtering each portion through methylene chloride-washed cotton into a 100-mL volumetric flask. Add methylene chloride to volume, and mix. Pipet 10 mL of this solution into a 50-mL centrifuge tube, evaporate the methylene chloride on a steam bath just to dryness, cool, and dissolve the residue in 10.0 mL of tetrahydrofuran and isooctane (1:1). Filter through a 1-µm membrane filter.
Procedure
Introduce equal volumes, about 10 µL, of the Assay preparation and the Standard preparation into a high-pressure liquid chromatograph (see Chromatography
100C(rU / rS)
in which C is the concentration, in mg per mL, of USP Prednisolone Tebutate RS in the Standard preparation, and rU and rS are the peak heights obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 4406
|